In this newsletter, we’d like to talk about how the Sooma treatment can be beneficial for fibromyalgia patients. Fibromyalgia is a type of chronic primary pain and there is sufficient clinical evidence that treatments such as the Sooma one have a positive effect on such condition.
It’s widespread pain that affects both sides of the body, above and below the waist as well as the axial skeletal system. The pain lasts for at least three months. In this condition, patients have 18 specifiс tender points as shown in the diagram:
Sooma Pain Therapy is a new tool that can be used alone or at the same time with other treatments, if there’s need to enhance their effect. The Sooma treatment’s side effect profile is different from common medications and may be tolerated by patients who have difficulties tolerating the medication. There is also no risk of developing an addiction.
Finally, Sooma Pain Therapy is easy to use. The setup takes two minutes, after which the patient can sit back and relax for 20 minutes. After the session, the patient may carry on with their regular activities right away.
Interested in finding out more? Head over to our website and, if you have any questions, get in touch via Facebook or Twitter!
tDCS induced electric fields: Electrodes at the level of deep nuclei show voltage changes during tDCS
Evidence of transcranial direct current stimulation-generated electric fields at subthalamic level in human brain in vivo
OCD: EEG activity patterns normalized after stimulation in patients with OCD
Normal Electrical Activity of the Brain in Obsessive-Compulsive Patients After Anodal Stimulation of the Left Dorsolateral Prefrontal Cortex
Cravings: Significant decrease in craving and modulation of brain networks after tDCS.
Transcranial DC stimulation modifies functional connectivity of large-scale brain networks in abstinent methamphetamine users.
Negative symptoms of Schizophrenia: Meta-analysis finds an effect-size of 0.50 for tDCS
Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: Meta-analysis of controlled trials.